James Vardiman to Myeloproliferative Disorders
This is a "connection" page, showing publications James Vardiman has written about Myeloproliferative Disorders.
Connection Strength
3.344
-
Myelodysplastic/myeloproliferative neoplasms. Semin Diagn Pathol. 2011 Nov; 28(4):283-97.
Score: 0.338
-
World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants. Hematology Am Soc Hematol Educ Program. 2011; 2011:250-6.
Score: 0.319
-
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact. 2010 Mar 19; 184(1-2):16-20.
Score: 0.294
-
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009 Nov; 6(11):627-37.
Score: 0.293
-
The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer. 2009 Sep 01; 115(17):3842-7.
Score: 0.291
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51.
Score: 0.283
-
Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2008 Jan; 22(1):14-22.
Score: 0.254
-
The diagnostic interface between histology and molecular tests in myeloproliferative disorders. Curr Opin Hematol. 2007 Mar; 14(2):115-22.
Score: 0.245
-
Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl. Best Pract Res Clin Haematol. 2006; 19(3):413-37.
Score: 0.226
-
Myelodysplastic/myeloproliferative diseases. Cancer Treat Res. 2004; 121:13-43.
Score: 0.197
-
Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases. Semin Diagn Pathol. 2003 Aug; 20(3):154-79.
Score: 0.191
-
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 05 19; 127(20):2391-405.
Score: 0.115
-
Hematopathologic findings in the myeloproliferative disorders. Semin Oncol. 1995 Aug; 22(4):355-73.
Score: 0.110
-
MPN-associated myelofibrosis (MPN-MF). Leuk Res. 2011 Jan; 35(1):12-3.
Score: 0.078
-
The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002 Oct 01; 100(7):2292-302.
Score: 0.045
-
Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am J Clin Pathol. 1993 Apr; 99(4):513-25.
Score: 0.023
-
Issues in the pathology of the myelodysplastic syndromes. Hematol Oncol Clin North Am. 1992 Jun; 6(3):501-22.
Score: 0.022
-
Development of dysmyelopoietic syndrome in a hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation. Cancer Genet Cytogenet. 1983 Feb; 8(2):107-15.
Score: 0.012
-
The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999 Dec; 10(12):1419-32.
Score: 0.009